BIO is most likely moving to find a higher trading range that better reflects the companies renewed growth prospects and the fact that they are positive cash flow and ebitda.
Free cash flow while achieving such strong sales growth may open the doors to a dividend which would be extraordinary because it’s very rare to see a company grow so fast and have too much cash.
The next growth chapter on this one is looking very interesting
good luck to holders
- Forums
- ASX - By Stock
- Ann: Biome Achieves Record Sales Revenue in FY24
BIO is most likely moving to find a higher trading range that...
Featured News
Add BIO (ASX) to my watchlist
|
|||||
Last
59.0¢ |
Change
0.020(3.51%) |
Mkt cap ! $126.9M |
Open | High | Low | Value | Volume |
57.5¢ | 64.0¢ | 56.5¢ | $985.9K | 1.625M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 9472 | 59.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
60.0¢ | 6000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 9472 | 0.590 |
2 | 27998 | 0.585 |
5 | 171085 | 0.580 |
4 | 18318 | 0.575 |
3 | 42500 | 0.570 |
Price($) | Vol. | No. |
---|---|---|
0.600 | 6000 | 1 |
0.610 | 4707 | 1 |
0.620 | 31120 | 2 |
0.625 | 8000 | 1 |
0.630 | 100000 | 1 |
Last trade - 16.10pm 03/07/2024 (20 minute delay) ? |
Featured News
BIO (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, CEO
James Graham
CEO
Previous Video
Next Video
SPONSORED BY The Market Online